For the Inventor, By the Inventor

Enter assignee name

Worcester, MA, United States of America

Athena Diagnostics, Inc.

USPTO Granted Patents = 23

% Expired Patents = 17.4

CIPO Patents = 8

EPO Patents = 1

Trademarks = 9

Forward Citations = 31

Loading Chart...

Loading Chart...

40 inventors (with patents filed for the assignee):

Corey D Braastad (9 out of 10 patents)

Jeffrey George Jones (9 out of 10 patents)

William K Seltzer (8 out of 8 patents)

4. Susan Kimberly Allen (8 out of 8 patents)

5. Sat Dev Batish (6 out of 6 patents)

6. Normand J Robichaud (6 out of 6 patents)

7. Narasimhan Nagan (5 out of 11 patents)

8. Hui Zhu (5 out of 6 patents)

9. Terry J Watnick (3 out of 6 patents)

10. Jeffery G Jones (3 out of 3 patents)

11. Gregory G Germino (3 out of 9 patents)

12. David A Hill (3 out of 3 patents)

13. Matthew Evans (3 out of 6 patents)

14. John A Curran (3 out of 3 patents)

15. Jing Wang (3 out of 3 patents)

23 patents: Sort by Forward Citations

1. 12497658 - METHODS TO DETECT A SILENT CARRIER GENOTYPE (2025-12-16),

2. 11655508 - PKD mutations and evaluation of same (2023-05-23),

3. 11512352 - Methods of detecting mutations associated with ataxia-ocular apraxia 2 (AOA2) (2022-11-29),

4. 10762981 - Pathogenicity scoring system for human clinical genetics (2020-09-01),

5. 10760128 - PKD mutations and evaluation of same (2020-09-01),

6. 10697016 - Methods to detect a silent carrier genotype (2020-06-30),

7. 10227650 - Methods to detect a silent carrier of a null allele genotype (2019-03-12),

8. 9611512 - Methods of detecting mutations associated with ataxia-ocular apraxia 2 (AOA2) (2017-04-04),

9. 8785122 - Methods of detecting mutations associated with ataxia-ocular apraxia 2 (AOA2) (2014-07-22),

10. 8771946 - PKD mutations and evaluation of same (2014-07-08),

11. 8192933 - Methods of detecting mutations associated with ataxia-ocular apraxia 2 (AOA2) (2012-06-05),

12. 7824860 - Application of aprataxin gene to diagnosis and treatment for early-onset spinocerebellar ataxia (EAOH) (2010-11-02),

13. 7799529 - Nephrin gene and protein (2010-09-21),

14. 7704691 - Methods of detecting mutations associated with ataxia-ocular apraxia 2 (AOA2) (2010-04-27),

15. 7521190 - Compositions and methods for genetic analysis of polycystic kidney disease (2009-04-21),

Athena Diagnostics, Inc. is a leading provider of advanced diagnostic testing services for neurological disorders. With over 30 years of experience, they specialize in offering genetic and biochemical testing for conditions such as Alzheimer's disease, epilepsy, and neuromuscular disorders. Their state-of-the-art laboratory and team of expert scientists ensure accurate and timely results, enabling healthcare professionals to provide personalized treatment plans for their patients. Visit their website to learn more about their comprehensive diagnostic solutions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

Athena Diagnostics, Inc.

23 Patents

#15 in Worcester, MA

#862 in Massachusetts

#14,383 in US

#27,581 in the World

Worcester, MA, United States of America

Athena Diagnostics, Inc.

Forward Citations = 31

40 inventors:

Corey D Braastad (9 out of 10 patents)

Jeffrey George Jones (9 out of 10 patents)

William K Seltzer (8 out of 8 patents)

4. Susan Kimberly Allen (8 out of 8 patents)

5. Sat Dev Batish (6 out of 6 patents)

Please report any incorrect information to [email protected]

Loading…